Alain Merieux - BioMrieux Director
| BMXMF Stock | USD 105.67 0.02 0.02% |
Director
Dr. Alain Merieux is Director of Biomerieux SA since January 1, 2011. He was Chairman of the Company Human Resources, Nominating and Remuneration Committee. He was previously Chairman of the Board of Directors at the Company until December 31, 2010. He was first appointed to the Company Board of Directors on July 10, 1986. Mr. Merieux has held several other posts, including Chairman of Fondation Merieux, Director of Transgene and Director of Compagnie Plastic Omnium, among others. He graduated from Harvard University in 1968. since 2011.
| Age | 78 |
| Tenure | 13 years |
| Phone | 33 4 78 87 20 00 |
| Web | https://www.biomerieux.com |
BioMrieux Management Efficiency
The company has return on total asset (ROA) of 0.1008 % which means that it generated a profit of $0.1008 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1751 %, meaning that it generated $0.1751 on every $100 dollars invested by stockholders. BioMrieux's management efficiency ratios could be used to measure how well BioMrieux manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Julie Overton | bioAffinity Technologies Warran | N/A | |
| Marvin Cadwell | RadNet Inc | 73 | |
| Mark Leventhal | ProPhase Labs | 55 | |
| Charles OData | Fonar | 82 | |
| Jason Barr | ProPhase Labs | 36 | |
| Cheryl Blanchard | Neuronetics | 53 | |
| David Cohen | Precipio | N/A | |
| Mark Burnett | ProPhase Labs | 56 | |
| Lawrence Levitt | RadNet Inc | 74 | |
| Jeffrey Cossman | Precipio | N/A | |
| Norman Hames | RadNet Inc | 68 | |
| Glenn Muir | Neuronetics | 59 | |
| Wilfred Jaeger | Neuronetics | 62 | |
| James McCubbin | ProPhase Labs | 51 | |
| Kathleen LaPorte | Precipio | 55 | |
| David Swartz | RadNet Inc | 73 | |
| Daniel Culver | Fonar | N/A | |
| Michael Luther | Precipio | 58 | |
| Douglas Fisher | Precipio | 39 | |
| Michael Sherman | RadNet Inc | 74 | |
| Ronald Lehman | Fonar | 41 | |
Management Performance
bioMrieux SA Leadership Team
Elected by the shareholders, the BioMrieux's board of directors comprises two types of representatives: BioMrieux inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioMrieux. The board's role is to monitor BioMrieux's management team and ensure that shareholders' interests are well served. BioMrieux's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioMrieux's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guillaume Bouhours, Corporate Vice President CFO, Member of the Executive Board | ||
| Fanny Letier, Independent Director | ||
| Frederic Beseme, Head CSR | ||
| Philippe Archinard, Director | ||
| Francois Lacoste, Member of the Management Committee, Director of Immunoassay Unit | ||
| Wei Ding, Member of the Management Committee, CEO of bioTheranostics | ||
| Alexandre Merieux, CEO, Director and Member of Strategy Committee | ||
| Kirk Ririe, Chief Innovation Officer | ||
| Alain Pluquet, CTO and Corporate VP of Innovation | ||
| Stefan Willemsen, Group Chief Legal Officer and Corporate VP of America Region | ||
| Claire Giraut, Member of the Management Committee and Corporate Vice President and CFO, Administrative Director | ||
| Harold Boel, Independent Director | ||
| Sylvain Morgeau, Head of Investor Relations | ||
| Pierre Boulud, Corporate Vice-President Asia-Pacific Region, Industrial Unit, Investments and Strategic Planning | ||
| Michel Baguenault, Member of the Management Committee, Director of Human Resources and Communication | ||
| Nicolas Cartier, Member of the Management Committee, Director of Industrial Microbiology Unit | ||
| MariePaule Kieny, Independent Director | ||
| Isabelle Tongio, Investor Relations Manager | ||
| Yasha Mitrotti, Corporate Vice President Europe, Middle East, Africa Region, Member of the Management Committee | ||
| Agnes Lemarchand, Independent Director | ||
| JeanLuc Belingard, Chairman of the Board | ||
| Philippe Gillet, Independent Director | ||
| Michele Palladino, Independent Director | ||
| Mark Miller, Member of the Management Committee, Chief Medical Officer and Head of Regulatory Affairs | ||
| Valerie Leylde, Communications HR | ||
| Pierre Charbonnier, Corporate Vice President Manufacturing & Supply Chain, Member of the Management Committee | ||
| Alain Merieux, Director | ||
| MarieHelene HabertDassault, Independent Director | ||
| Randy Rasmussen, Corporate Vice President Molecular Biology, Member of the Management Committee | ||
| Franois Lacoste, Ex RD |
BioMrieux Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is BioMrieux a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 11.99 B | |||
| Shares Outstanding | 118.37 M | |||
| Shares Owned By Insiders | 64.28 % | |||
| Shares Owned By Institutions | 18.40 % | |||
| Price To Earning | 23.91 X | |||
| Price To Book | 3.18 X |
Pair Trading with BioMrieux
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioMrieux position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMrieux will appreciate offsetting losses from the drop in the long position's value.Moving against BioMrieux Pink Sheet
| 0.41 | CVI | CVR Energy Financial Report 6th of May 2024 | PairCorr |
The ability to find closely correlated positions to BioMrieux could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioMrieux when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioMrieux - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling bioMrieux SA to buy it.
The correlation of BioMrieux is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioMrieux moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if bioMrieux SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioMrieux can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioMrieux SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for BioMrieux Pink Sheet analysis
When running BioMrieux's price analysis, check to measure BioMrieux's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioMrieux is operating at the current time. Most of BioMrieux's value examination focuses on studying past and present price action to predict the probability of BioMrieux's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioMrieux's price. Additionally, you may evaluate how the addition of BioMrieux to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |